Vigil Neuroscience, Inc. financial data

Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 05 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 290% % -74%
Debt-to-equity 66% % 216%
Return On Equity -138% % -82%
Return On Assets -83% % -32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47,701,161 shares 20%
Common Stock, Shares, Outstanding 47,686,561 shares 27%
Entity Public Float $106,100,000 USD -54%
Common Stock, Value, Issued $5,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 47,619,724 shares 17%
Weighted Average Number of Shares Outstanding, Diluted 47,619,724 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $66,361,000 USD 6.9%
General and Administrative Expense $30,389,000 USD 8.5%
Operating Income (Loss) $96,750,000 USD -7.4%
Nonoperating Income (Expense) $4,585,000 USD -26%
Net Income (Loss) Attributable to Parent $92,165,000 USD -9.9%
Earnings Per Share, Basic -2 USD/shares 0.94%
Earnings Per Share, Diluted -2 USD/shares 0.94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $41,214,000 USD 10%
Marketable Securities, Current $25,771,000 USD -48%
Other Assets, Current $1,002,000 USD 6.7%
Assets, Current $70,293,000 USD -22%
Property, Plant and Equipment, Net $1,430,000 USD -6.8%
Operating Lease, Right-of-Use Asset $14,010,000 USD -9.3%
Other Assets, Noncurrent $21,000 USD -93%
Assets $86,699,000 USD -20%
Accounts Payable, Current $1,551,000 USD 9.4%
Employee-related Liabilities, Current $2,603,000 USD 16%
Contract with Customer, Liability, Current $20,009,000 USD 0.04%
Liabilities, Current $34,112,000 USD 217%
Operating Lease, Liability, Noncurrent $11,331,000 USD -8.9%
Liabilities $45,443,000 USD 96%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,000 USD
Retained Earnings (Accumulated Deficit) $356,104,000 USD -35%
Stockholders' Equity Attributable to Parent $41,256,000 USD -52%
Liabilities and Equity $86,699,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,893,000 USD -9.2%
Net Cash Provided by (Used in) Financing Activities $13,267,000 USD 156%
Net Cash Provided by (Used in) Investing Activities $23,227,000 USD 41%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 47,730,884 shares 27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,601,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42,141,000 USD 10%
Deferred Tax Assets, Valuation Allowance $95,677,000 USD 38%
Deferred Tax Assets, Gross $99,671,000 USD 36%
Operating Lease, Liability $12,437,000 USD -7.2%
Payments to Acquire Property, Plant, and Equipment $285,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $92,138,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid $16,368,000 USD -11%
Property, Plant and Equipment, Gross $2,200,000 USD 0.23%
Operating Lease, Liability, Current $1,106,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,027,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,088,000 USD 6.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,931,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,088,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $36,726,000 USD 40%
Preferred Stock, Shares Issued 537,634 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Preferred Stock, Shares Outstanding 537,634 shares
Deferred Tax Assets, Net of Valuation Allowance $3,994,000 USD -9.7%
Share-based Payment Arrangement, Expense $10,284,000 USD 3.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%